Influenza epidemiology and vaccine effectiveness during the 2023/2024 season in Italy: A test-negative case-control study
Open Access
- 8 August 2024
- journal article
- research article
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 147, 107202
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- The need for a clinical case definition in test-negative design studies estimating vaccine effectivenessnpj Vaccines, 2023
- Influenza vaccine effectiveness in preventing hospital encounters for laboratory-confirmed infection among Italian adults, 2022/23 seasonVaccine, 2023
- Cost-effectiveness of routine annual influenza vaccination by age and risk statusVaccine, 2023
- Vaccine effectiveness of recombinant and standard dose influenza vaccines against outpatient illness during 2018–2019 and 2019–2020 calculated using a retrospective test-negative designHuman Vaccines & Immunotherapeutics, 2023
- Comparative effectiveness of adjuvanted versus high-dose seasonal influenza vaccines for older adults: a systematic review and meta-analysisInternational Journal of Infectious Diseases, 2022
- A Retrospective Test-Negative Case-Control Study to Evaluate Influenza Vaccine Effectiveness in Preventing Hospitalizations in ChildrenClinical Infectious Diseases, 2021
- Longitudinal symptom dynamics of COVID-19 infectionNature Communications, 2020
- Investigating the impact of influenza on excess mortality in all ages in Italy during recent seasons (2013/14–2016/17 seasons)International Journal of Infectious Diseases, 2019
- Theoretical Basis of the Test-Negative Study Design for Assessment of Influenza Vaccine EffectivenessAmerican Journal of Epidemiology, 2016
- Influenza vaccine effectiveness estimates for Western Australia during a period of vaccine and virus strain stability, 2010 to 2012Vaccine, 2014